Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04514497
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2020-08-14
Brief Title:
Testing the Addition of an Anti-cancer Drug BAY 1895344 to Usual Chemotherapy for Advanced Stage Solid Tumors With a Specific Focus on Patients With Small Cell Lung Cancer Poorly Differentiated Neuroendocrine Cancer and Pancreatic Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Lung Small Cell Carcinoma |
| Metastatic Malignant Solid Neoplasm |
| Metastatic Neuroendocrine Carcinoma |
| Metastatic Pancreatic Adenocarcinoma |
| Stage III Lung Cancer AJCC v8 |
| Stage III Pancreatic Cancer AJCC v8 |
| Stage IV Lung Cancer AJCC v8 |
| Stage IV Pancreatic Cancer AJCC v8 |
| Unresectable Lung Small Cell Carcinoma |
| Unresectable Malignant Solid Neoplasm |
| Unresectable Neuroendocrine Carcinoma |
| Unresectable Pancreatic Adenocarcinoma |
Keywords: